Furthermore, higher Siglec-7 expression correlated with poor clinicopathological features, including negative Estrogen Receptor (ER) and Progesterone Receptor (PR) status, advanced tumor grades, and unfavorable patient prognosis. Here, ESR1 is linked to neoplasm.